Society for Immunotherapy of Cancer to Host Leadership Institute Focusing on Professional Development of Women in Cancer Immunotherapy

Share Article

On International Women’s Day, the Society for Immunotherapy of Cancer (SITC) is pleased to announce a new initiative focused on women in the field. The Women in Cancer Immunotherapy Network Leadership Institute is a one-and-a-half day, free program that seeks to celebrate and empower emerging female leaders in the cancer immunotherapy field.

Society for Immunotherapy of Cancer

“As the successor to SITC’s first female president, I am privileged to continue and expand our society’s support of women involved with research and development in the laboratory, clinic, industry and all other areas related to immuno-oncology,” said SITC President Mario Sznol, MD.

On International Women’s Day, the Society for Immunotherapy of Cancer (SITC) is pleased to announce a new initiative focused on women in the field. The Women in Cancer Immunotherapy Network Leadership Institute is a one-and-a-half day, free program that seeks to celebrate and empower emerging female leaders in the cancer immunotherapy field.

Scheduled for Aug. 19–20, 2019, in Seattle, the Women in Cancer Immunotherapy Network Leadership Institute will provide a forum for female scientists and clinicians to network with luminaries in the field while exploring topics particularly relevant to them in the workplace, including negotiation techniques, breaking through the glass ceiling, conflict resolution strategies and public speaking. The program, which includes an application process, will be free to attend.

“As the successor to SITC’s first female president, I am privileged to continue and expand our society’s support of women involved with research and development in the laboratory, clinic, industry and all other areas related to immuno-oncology,” said SITC President Mario Sznol, MD.

Championed by SITC Immediate Past President Lisa H. Butterfield, PhD, the Women in Cancer Immunotherapy Network (WIN) is a SITC initiative launched in 2017 that has included annual receptions celebrating women in cancer immunotherapy. The discussions at these receptions have identified strategies to elevate the status of women, both within the society through general leadership roles and faculty opportunities, as well as the field in general.

“As the first female President of SITC, shining the spotlight on the contributions women have made, and continue to make, in cancer immunotherapy and tumor immunology research was a major personal focus,” said Dr. Butterfield. “The Leadership Institute is our society’s next step in providing a professional development opportunity to further support our field’s female researchers and clinicians.”

Women interested in attending the WIN Leadership Institute are encouraged to submit an application by April 15 at 11:59 p.m. EST. The one-and-a-half day program will take place at the Seattle Waterfront Marriott Hotel, 2100 Alaskan Way, in Seattle, Wash. Click here to view a current schedule for this program.

About SITC
The Society for Immunotherapy of Cancer (SITC) is the world’s leading member-driven organization specifically dedicated to improving cancer patient outcomes by advancing the science and application of cancer immunotherapy. Established in 1984, SITC, a 501(c)(3) not-for-profit organization, serves scientists, clinicians, academicians, patients, patient advocates, government representatives and industry leaders from around the world. Through educational programs that foster scientific exchange and collaboration, SITC aims to one day make the word cure a reality for cancer patients everywhere. To learn more, visit https://www.sitcancer.org/home

Share article on social media or email:

View article via:

Pdf Print

Contact Author

Julia Schultz, Director of Communications
@sitcancer
Follow >
Society for Immunotherapy of Cancer
Like >
Visit website